The investigated pirinixic acid derivatives modulate 5-LO, mPGES1, PPARα, and PPARγ at varying potencies [3–8] and these molecules are considered as potential anti-cancer drug targets [14–17]. The gene discussed is PPARA; the disease is cancer.